切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - ErbB-2 - Tie-2 - c-Fyn - Toll-like receptors (TLRs)

13件产品中的 1-10

页面
每页
清除全部
  1. Pexmetinib (ARRY-614)
    B6012 Pexmetinib (ARRY-614)
    Target: p38|Tie-2
    Summary: p38 MAPK 和 Tie2/Tek 受体酪氨酸激酶的双重抑制剂
      ≥107.6 mg/mL
      insoluble in H2O
  2. Altiratinib
    B5832 Altiratinib
     1 Citation
    Target: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2
    Summary: c-MET/TIE-2/VEGFR抑制剂
      ≥21.55 mg/mL
      insoluble in H2O
  3. ACTB-1003
    B4904 ACTB-1003
    Target: VEGFR|FGFR|Tie-2|RSK|p70 S6K
    Summary: FGFR1抑制剂
      ≥18.15 mg/mL
      insoluble in H2O
  4. Hydroxychloroquine Sulfate
    B4874 Hydroxychloroquine Sulfate
    中文名: 羟氯喹
    Target: Toll-like receptors (TLRs)|Autophagy
    Summary: 自噬抑制剂
      insoluble in DMSO
      ≥17.6 mg/mL
  5. Poly(I:C)
    B5551 Poly(I:C)
    Target: Toll-like receptors (TLRs)
    Summary: Toll样受体3(TLR3)激动剂
      insoluble in DMSO
      ≥21.5 mg/mL
  6. 1-NM-PP1
    B1299 1-NM-PP1
    Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-Fyn
    Summary: Pp60c-src抑制剂
      ≥16.55 mg/mL
      insoluble in H2O
  7. Resiquimod (R-848)
    B1054 Resiquimod (R-848)
     2 Citation
    中文名: 雷西莫特,瑞喹莫德
    Target: Toll-like receptors (TLRs)
    Summary: 免疫应答调节剂
      ≥15.85 mg/mL
      insoluble in H2O
  8. DCC-2036 (Rebastinib)
    B1404 DCC-2036 (Rebastinib)
    Target: FLT3|Bcr-Abl|Tie-2|KDR
    Summary: Bcr-Abl抑制剂
      ≥27.7 mg/mL
  9. Tie2 kinase inhibitor
    A5979 Tie2 kinase inhibitor
    中文名: Tie2激酶抑制剂
    Target: Tie-2
    Summary: Tie-2(Tie2 )抑制剂
      ≥22 mg/mL
      insoluble in H2O
  10. Imiquimod
    A5161 Imiquimod
    中文名: 咪喹莫特
    Target: Toll-like receptors (TLRs)
    Summary: TLR-7激动剂,具有抗病毒和抗肿瘤活性的免疫调节剂
      ≥1.2 mg/mL
      insoluble in H2O

13件产品中的 1-10

页面
每页